Anjali K. Gupta

发表

Cell cycle dependent and schedule-dependent antitumor effects of sorafenib combined with radiation.

K. Flaherty, A. Rustgi, W. El-Deiry, 2007, Cancer research.

Signaling Pathways in NSCLC as a Predictor of Outcome and Response to Therapy

M. Feldman, R. Muschel, S. Hahn, 2004, Lung.

Inhibiting Signal Transduction as an Approach to Radiosensitizing Tumor Cells

R. Muschel, S. Hahn, E. Bernhard, 2003 .

Immune response during therapy with cisplatin or radiation for human papillomavirus-related head and neck cancer.

Anjali K. Gupta, Mary E. Anderson, John H. Lee, 2009, Archives of otolaryngology--head & neck surgery.

Ras Signaling and Its Inhibition with Farnesyltransferase Inhibitors: Effects on Radiation Resistance and the Tumor Microenvironment

R. Muschel, S. Hahn, E. Bernhard, 2003 .

Signaling inhibition with radiation in colorectal cancer: Clinical trials

R. Muschel, S. Hahn, E. Bernhard, 2003 .

Molecular Aspects of Radiation Biology

W. Mckenna, G. Kao, Anjali K. Gupta, 2002 .

Hypoglycemia-induced c-Jun Phosphorylation Is Mediated by c-Jun N-terminal Kinase 1 and Lyn Kinase in Drug-resistant Human Breast Carcinoma MCF-7/ADR Cells*

Anjali K. Gupta, Y. Lee, Xin Liu, 1997, The Journal of Biological Chemistry.

Bortezomib sensitizes human head and neck carcinoma cells SQ20B to radiation

A. Maity, G. Cerniglia, Anjali K. Gupta, 2007, Cancer biology & therapy.

Outcomes after the use of gastrostomy tubes in patients whose head and neck cancer was managed with radiation therapy

D. V. Van Daele, G. Funk, L. Karnell, 2011, Head & neck.

Radiation sensitization of human cancer cells in vivo by inhibiting the activity of PI3K using LY294002.

Rosemarie Mick, R. Muschel, W. Mckenna, 2003, International journal of radiation oncology, biology, physics.

Differential effect of glucose deprivation on MAPK activation in drug sensitive human breast carcinoma MCF-7 and multidrug resistant MCF-7/ADR cells

K. Guan, Anjali K. Gupta, P. Corry, 1997, Molecular and Cellular Biochemistry.

A Phase I Trial of the Dual Farnesyltransferase and Geranylgeranyltransferase Inhibitor L-778,123 and Radiotherapy for Locally Advanced Pancreatic Cancer

E. Rosato, J. Tepper, P. Deutsch, 2004, Clinical Cancer Research.

The influence of Ras pathway signaling on tumor radiosensitivity

E. Bernhard, W. Mckenna, Anjali K. Gupta, 2004, Cancer and Metastasis Reviews.

Farnesyltransferase inhibitors: an overview of the results of preclinical and clinical investigations.

R. Muschel, S. Hahn, E. Bernhard, 2003, Cancer research.

Signaling pathways in adenoid cystic cancers: Implications for treatment

J. Buatti, M. Milhem, Anjali K. Gupta, 2009, Cancer biology & therapy.

The RAS signal transduction pathway and its role in radiation sensitivity

R. Muschel, S. Hahn, E. Bernhard, 2003, Oncogene.

C-Raf-1 Protein Kinase Is Not Essential for Ras Transformation of Mouse Embryo Fibroblasts

R. Muschel, E. Bernhard, V. Bakanauskas, 2003, Cancer biology & therapy.

32 C-RAF-1 protein kinase is not essential for ras transformation in mouse embryo fibroblasts

R. Muschel, E. Bernhard, W. Mckenna, 1999 .

Phosphatase and tensin homologue deficiency in glioblastoma confers resistance to radiation and temozolomide that is reversed by the protease inhibitor nelfinavir.

S. Hahn, E. Bernhard, A. Maity, 2007, Cancer research.

The HIV protease inhibitor nelfinavir downregulates Akt phosphorylation by inhibiting proteasomal activity and inducing the unfolded protein response.

S. Hahn, A. Maity, G. Cerniglia, 2007, Neoplasia.

HIV protease inhibitors decrease VEGF/HIF-1alpha expression and angiogenesis in glioblastoma cells.

A. Maity, G. Cerniglia, Anjali K. Gupta, 2006, Neoplasia.

Nelfinavir down-regulates hypoxia-inducible factor 1alpha and VEGF expression and increases tumor oxygenation: implications for radiotherapy.

S. Hahn, E. Bernhard, A. Maity, 2006, Cancer research.

HIV protease inhibitors block Akt signaling and radiosensitize tumor cells both in vitro and in vivo.

Rosemarie Mick, R. Muschel, W. Mckenna, 2005, Cancer research.

Adverse events associated with concurrent chemoradiation therapy in patients with head and neck cancer.

Nitin A. Pagedar, D. V. Van Daele, G. Funk, 2009, Archives of otolaryngology--head & neck surgery.

EGFR tyrosine kinase inhibitors decrease VEGF expression by both hypoxia-inducible factor (HIF)-1-independent and HIF-1-dependent mechanisms.

A. Maity, G. Kao, G. Cerniglia, 2006, Cancer research.

Clinical Outcomes of the HIV Protease Inhibitor Nelfinavir With Concurrent Chemoradiotherapy for Unresectable Stage IIIA/IIIB Non-Small Cell Lung Cancer: A Phase 1/2 Trial.

C. Simone, S. Hahn, A. Maity, 2019, JAMA oncology.

Local recurrence in head and neck cancer: relationship to radiation resistance and signal transduction.

R. Weber, R. Muschel, M. Feldman, 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

HIV Protease Inhibitors Decrease VEGF / HIF-1 A Expression and Angiogenesis in Glioblastoma Cells 1

A. Maity, G. Cerniglia, Anjali K. Gupta, 2006 .

Inhibition of Phosphatidylinositol-3-OH Kinase/Akt Signaling Impairs DNA Repair in Glioblastoma Cells following Ionizing Radiation*

A. Maity, G. Kao, Anjali K. Gupta, 2007, Journal of Biological Chemistry.

Radiation response in two HPV-infected head-and-neck cancer cell lines in comparison to a non-HPV-infected cell line and relationship to signaling through AKT.

J. Buatti, H. Quon, A. Maity, 2009, International journal of radiation oncology, biology, physics.

RAS-Mediated Radiation Resistance is not Linked to MAP Kinase Activation in Two Bladder Carcinoma Cell Lines

R. Muschel, E. Bernhard, W. Mckenna, 2000, Radiation research.

The Ras Radiation Resistance Pathway 1

R. Muschel, E. Bernhard, W. Mckenna, 2001 .

Implications for Radiotherapy VEGF Expression and Increases Tumor Oxygenation : and α Nelfinavir Down-regulates Hypoxia-Inducible Factor 1

S. Hahn, E. Bernhard, A. Maity, 2006 .

Effect of Ionizing Radiation on AP-1 Binding Activity and Basic Fibroblast Growth Factor Gene Expression in Drug-sensitive Human Breast Carcinoma MCF-7 and Multidrug-resistant MCF-7/ADR Cells *

D. K. Ways, Anjali K. Gupta, G. Erdos, 1995, The Journal of Biological Chemistry.

Investigation of the pharmacokinetics of 3'-deoxy-3'-[18F]fluorothymidine uptake in the bone marrow before and early after initiation of chemoradiation therapy in head and neck cancer.

John M Buatti, John J Sunderland, Yusuf Menda, 2010, Nuclear medicine and biology.

In Reply to Drs. Vozenin-Brotons and Deutsch

Anjali K. Gupta, 2011 .

The Ras radiation resistance pathway.

R. Muschel, E. Bernhard, W. Mckenna, 2001, Cancer research.

Iridium-192 transperineal interstitial brachytherapy for locally advanced or recurrent gynecological malignancies.

G. Gustafson, F. Vicini, A. Martinez, 1999, International journal of radiation oncology, biology, physics.

Direct evidence for the contribution of activated N-ras and K-ras oncogenes to increased intrinsic radiation resistance in human tumor cell lines.

R. Muschel, E. Stanbridge, E. Bernhard, 2000, Cancer research.

Farnesyltransferase inhibitors as radiation sensitizers

R. Muschel, S. Hahn, Y. Shi, 2003, Seminars in radiation oncology.

Farnesyltransferase inhibitors: an overview of the results of preclinical and clinical investigations.

R. Muschel, S. Hahn, E. Bernhard, 2003, Cancer research.

Signaling inhibition with radiation in colorectal cancer: clinical trials.

R. Muschel, S. Hahn, E. Bernhard, 2003, Seminars in oncology.

A Phase I Trial of the HIV Protease Inhibitor Nelfinavir with Concurrent Chemoradiotherapy (CT-RT) for Stage IIIA/IIIB NSCLC: A Report of Toxicities and Metabolic Response

S. Hahn, A. Maity, C. Langer, 2009 .